These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 27272371)

  • 21. Use of intramuscular methadone in managing intravenous drug abuse.
    Bezant EM
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25414219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized cutaneous polyvinylpyrrolidone storage disease mimicking cheilitis granulomatosa.
    Chi CC; Wang SH; Kuo TT
    J Cutan Pathol; 2006 Jun; 33(6):454-7. PubMed ID: 16776723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with methadone treatment among injection drug users in Bangkok, Thailand.
    Fairbairn N; Hayashi K; Kaplan K; Suwannawong P; Qi J; Wood E; Kerr T
    J Subst Abuse Treat; 2012 Jul; 43(1):108-13. PubMed ID: 22154035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Another Senseless Death - The Case for Supervised Injection Facilities.
    Wakeman SE
    N Engl J Med; 2017 Mar; 376(11):1011-1013. PubMed ID: 28296603
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive burdens of malnutrition, poverty, and substance abuse.
    Sigmon SC
    Lancet; 2016 Oct; 388(10054):1879-1880. PubMed ID: 27751393
    [No Abstract]   [Full Text] [Related]  

  • 28. Anaphylaxis to polyvinylpyrrolidone in povidone-iodine for impetigo contagiosum in a boy with atopic dermatitis.
    Yoshida K; Sakurai Y; Kawahara S; Takeda T; Ishikawa T; Murakami T; Yoshioka A
    Int Arch Allergy Immunol; 2008; 146(2):169-73. PubMed ID: 18204285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated candidiasis after intravenous use of oral methadone.
    Scheidegger C; Pietrzak J; Frei R
    Ann Intern Med; 1991 Oct; 115(7):576. PubMed ID: 1883129
    [No Abstract]   [Full Text] [Related]  

  • 31. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left cardiac sympathetic denervation for the treatment of methadone-induced long QT syndrome.
    Miller MA; Bhasin K; Reddy VY; d'Avila A
    Heart Rhythm; 2011 Dec; 8(12):1955-7. PubMed ID: 21782777
    [No Abstract]   [Full Text] [Related]  

  • 33. [Predictors of retention related factors at the initial methadone maintenance treatment clinics in Guangdong province].
    Chen A; Xia YH; Chen W; Ling L; Tan WK; Zheng RJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Dec; 30(12):1230-3. PubMed ID: 20193303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monitoring and evaluation of the Hungarian methadone maintenance programmes].
    Rácz J; Melles K; Márványkövi F; Vadász V
    Psychiatr Hung; 2010; 25(3):202-20. PubMed ID: 20884995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aanaphylactic shock due to povidone.
    Moreno-Escobosa MC
    J Paediatr Child Health; 2017 May; 53(5):517. PubMed ID: 28470810
    [No Abstract]   [Full Text] [Related]  

  • 36. No opiate substitutes for the masses of IDUs.
    Cohen J
    Science; 2010 Jul; 329(5988):165-7. PubMed ID: 20616264
    [No Abstract]   [Full Text] [Related]  

  • 37. The physical health of people who inject drugs: complexities, challenges, and continuity.
    Cornford C; Close H
    Br J Gen Pract; 2016 Jun; 66(647):286-7. PubMed ID: 27231287
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal lipidosis in patients enrolled in a methadone substitution program.
    Porubsky S; Kuppe C; Maier T; Birk HW; Wörnle M; Moeller MJ; Floege J; Gröne HJ
    Arch Pathol Lab Med; 2014 May; 138(5):689-93. PubMed ID: 24786128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First, do no harm: QT interval screening in methadone maintenance treatment.
    Haigney MC
    J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management.
    Ferrando SJ; Batki SL
    J Psychoactive Drugs; 1991; 23(2):217-24. PubMed ID: 1662716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.